
BioAdaptives Announces Aug. 1 Launch of XcellaraHeart Cardiovascular Supplement Combining Stem Cell Mobilization with Tanshinone IIA
BioAdaptives' XcellaraHeart supplement, launching Aug. 1, 2026, combines a clinically proven stem cell mobilizer with Tanshinone IIA to support cardiovascular repair, highlighting a novel approach to wellness.
Read full story




















